You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Chemokines and their receptors in the esophageal carcinoma tumor microenvironment: key factors for metastasis and progression
- 2. Scientists create a type of catalog, the 'colocatome,' of non-cancerous cells' influence on cancer
- 3. Walking, moving more may lower risk of cardiovascular death for women with cancer history
- 4. Revolutionising cancer treatment: targeting EZH2 for a new era of precision medicine
- 5. Mapping clinical and imaging factors that might predict cardiac events in breast cancer patients
- 6. Integrating quantitative DCE-MRI parameters and radiomic features for improved IDH mutation prediction in gliomas
- 7. Efficacy of thunder-fire moxibustion for cancer-related fatigue in breast cancer survivors: study protocol for a randomized controlled trial
- 8. EZH2: An analysis of a potential new tumor marker in high-risk localization of cutaneous squamous cell carcinomas
- 9. New avenues in breast cancer treatment: The role of ubiquitin-specific proteases in programmed cell death
- 10. Pfizer and Arvinas's HER2-breast cancer drug extends PFS in certain patients
Last updated at 11:25 GMT
Hot News Makers
Health/Pharma Companies
-
192009.99
-
76052.68
-
30938.61
-
27592.28
-
26846.55
-
22225.81
-
14127.72
-
9431.62
-
5940.03
-
4295.34
Drugs, Treatments, Trials
-
18467.02
-
13402.17
-
6287.43
-
5557.81
-
4765.79
-
2849.28
-
2681.67
-
2532.69
-
2434.48
-
1519.62
Last updated at 11:10 GMT
